These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits. Qiao Z; Ren J; Chen H J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685 [TBL] [Abstract][Full Text] [Related]
8. Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂. Rizos CV; Liberopoulos EN; Tellis CC; Florentin M; Elisaf MS; Tselepis AD Metab Syndr Relat Disord; 2011 Jun; 9(3):217-23. PubMed ID: 21352079 [TBL] [Abstract][Full Text] [Related]
9. Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial. Ridker PM; MacFadyen JG; Wolfert RL; Koenig W Clin Chem; 2012 May; 58(5):877-86. PubMed ID: 22419750 [TBL] [Abstract][Full Text] [Related]
10. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study. Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472 [TBL] [Abstract][Full Text] [Related]
11. Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosis. Ferguson JF; Hinkle CC; Mehta NN; Bagheri R; Derohannessian SL; Shah R; Mucksavage MI; Bradfield JP; Hakonarson H; Wang X; Master SR; Rader DJ; Li M; Reilly MP J Am Coll Cardiol; 2012 Feb; 59(8):764-72. PubMed ID: 22340269 [TBL] [Abstract][Full Text] [Related]
12. Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL-cholesterol concentration in baboons fed an atherogenic diet. Vinson A; Mahaney MC; Diego VP; Cox LA; Rogers J; VandeBerg JL; Rainwater DL J Lipid Res; 2008 Jun; 49(6):1295-302. PubMed ID: 18334716 [TBL] [Abstract][Full Text] [Related]
13. Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis. Vickers KC; Maguire CT; Wolfert R; Burns AR; Reardon M; Geis R; Holvoet P; Morrisett JD J Lipid Res; 2009 Sep; 50(9):1735-43. PubMed ID: 19359705 [TBL] [Abstract][Full Text] [Related]
14. Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis. Zhang FJ; Cai MJ; Shen JK; Wang YP Acta Pharmacol Sin; 2006 Jun; 27(6):679-84. PubMed ID: 16723085 [TBL] [Abstract][Full Text] [Related]
15. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A; J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke. Caslake MJ; Packard CJ Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):529-35. PubMed ID: 16186851 [TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females. Nelson TL; Hokanson JE; Hickey MS Eur J Nutr; 2011 Apr; 50(3):185-93. PubMed ID: 20706728 [TBL] [Abstract][Full Text] [Related]